Anderbro Therese Carin, Amsberg Susanne, Moberg Erik, Gonder-Frederick Linda, Adamson Ulf, Lins Per-Eric, Johansson Unn-Britt
Department of Clinical Sciences Karolinska Institutet Danderyd Hospital Stockholm Sweden.
Department of Psychology Stockholm University Stockholm Sweden.
Endocrinol Diabetes Metab. 2018 Feb 14;1(2):e00013. doi: 10.1002/edm2.13. eCollection 2018 Apr.
To investigate fear of hypoglycaemia (FoH) longitudinally in a cross-sectional study of adult patients with type 1 diabetes. Specifically, we investigated two subgroups of patients who over 4 years either showed a substantial increase or decrease in level of FoH to identify factors associated with changes in FoH.
The Swedish version of the Hypoglycaemia Fear Survey (HFS) along with a questionnaire to assess hypoglycaemia history was sent by mail to 764 patients in 2010. The responders in 2010 (n = 469) received another set of the same two questionnaires in 2014. HbA, insulin regimen, weight and creatinine from 2010 and 2014 were obtained from medical records. Those with an absolute difference in HFS scores ≥ 75th percentile were included in the subgroup analyses. Statistical analyses included one-sample t tests, chi-square and McNemar's test.
The absolute difference in the HFS total score (n = 347) between 2010 and 2014 was m = ±7.6, SD ± 6. In the increased FoH group, more patients reported a high level of moderate hypoglycaemic episodes as well as impaired awareness of hypoglycaemia in 2014 compared with the decreased FoH group. There were more subjects in the increased FoH group with insulin pumps in 2014 and in 2010. In the decreased FoH group, more patients had a high frequency of daily self-monitoring of blood glucose (SMBG) in 2010 and in 2014.
Fear of hypoglycaemia is stable across time for most patients. Changes in fear level are associated with changes in hypoglycaemia frequency. Thus, asking patients about changes in hypoglycaemia experiences is of great importance.
在一项针对 1 型糖尿病成年患者的横断面研究中纵向调查低血糖恐惧(FoH)。具体而言,我们调查了两组患者亚组,这两组患者在 4 年期间 FoH 水平要么有大幅上升,要么有大幅下降,以确定与 FoH 变化相关的因素。
2010 年通过邮件向 764 名患者发送了瑞典版低血糖恐惧调查问卷(HFS)以及一份评估低血糖病史的问卷。2010 年的应答者(n = 469)在 2014 年又收到了同样的两份问卷。从医疗记录中获取 2010 年和 2014 年的糖化血红蛋白、胰岛素治疗方案、体重和肌酐数据。HFS 评分绝对差异≥第 75 百分位数的患者纳入亚组分析。统计分析包括单样本 t 检验、卡方检验和 McNemar 检验。
2010 年至 2014 年 HFS 总分(n = 347)的绝对差异为 m = ±7.6,标准差±6。与 FoH 降低组相比,FoH 增加组在 2014 年有更多患者报告中度低血糖发作水平较高以及低血糖意识受损。在 2014 年和 2010 年,FoH 增加组中使用胰岛素泵的受试者更多。在 FoH 降低组中,2010 年和 2014 年有更多患者每日自我血糖监测(SMBG)频率较高。
大多数患者的低血糖恐惧随时间推移较为稳定。恐惧水平的变化与低血糖频率的变化相关。因此,询问患者低血糖经历的变化非常重要。